Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Caspian J Intern Med ; 11(3): 333-336, 2020 May.
Artigo em Inglês | MEDLINE | ID: mdl-32874443

RESUMO

BACKGROUND: Foreign body insertion in the urethra and bladder are relatively rare. These patients usually insert foreign body in urethra for eroticism, inquisitiveness, or as a consequence of disinhibited or disturbed behavior. CASE PRESENTATION: Herein, we report a case of 41-year-old man presented with weak stream and suprapubic pain. Due to incontinence, he instilled superglue into his urethra. On perineal examination, a foreign body was palpable in the penile urethra. A 10 cm dried superglue block got out with incision at glance. CONCLUSION: Urethral foreign bodies are mostly found on physical examination and clinical history. Although imaging modalities are commonly used for FBs detection, the necessity of imaging modalities are still a controversy.

2.
PLoS Negl Trop Dis ; 13(12): e0007809, 2019 12.
Artigo em Inglês | MEDLINE | ID: mdl-31856156

RESUMO

BACKGROUND: Human toxocariasis is an important neglected disease. We performed a systematic review and meta-analysis study to estimate the global and regional prevalence of anti-Toxocara serum antibodies (referred to as 'T-seroprevalence') in human populations around the world. METHODS: We searched five international databases (PubMed, EMBASE, Web of Science, SciELO and Scopus) for seroprevalence studies published from 1 January 1980 to 15 March 2019. We used random effect models to calculate the overall T-seroprevalence (with 95% CIs) in all six WHO regions and worldwide. We also conducted subgroup and linear meta-regression analyses to evaluate the impact of socio-demographic, geographical and climatic parameters on seroprevalence. RESULTS: We identified 250 eligible studies (253 datasets) comprising 265,327 participants in 71 countries for inclusion in the present meta-analysis. The estimated global T-seroprevalence rate was 19.0% (95%CI, 16.6-21.4%; 62,927/265,327); seroprevalence was highest in the African region (37.7%; 25.7-50.6%) and lowest in the Eastern Mediterranean region (8.2%; 5.1-12.0%). The pooled seroprevalence for other WHO regions was 34.1% (20.2-49.4%) in the South-East Asia; 24.2% (16.0-33.5%) in the Western Pacific; 22.8% (19.7-26.0%) in the American; and 10.5% (8.5-12.8%) in the European regions. A significantly higher T-seroprevalence was associated with a lower income level; lower human development index (HDI); lower latitude; higher humidity; higher temperature; and higher precipitation (P-value < 0.001). Potential risk factors associated with seropositivity to Toxocara included male gender; living in a rural area; young age; close contact with dogs, cats or soil; consumption of raw meat; and the drinking of untreated water. CONCLUSIONS: The present findings indicate high levels of infection with, or exposure to Toxocara spp. in many countries, which calls for increased attention to human toxocariasis and improved measures to prevent adverse health risks of this disease.


Assuntos
Anticorpos Anti-Helmínticos/sangue , Toxocara/imunologia , Toxocaríase/epidemiologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Animais , Criança , Pré-Escolar , Feminino , Saúde Global , Humanos , Lactente , Recém-Nascido , Masculino , Pessoa de Meia-Idade , Fatores de Risco , Estudos Soroepidemiológicos , Adulto Jovem
3.
Brain Res Bull ; 142: 281-288, 2018 09.
Artigo em Inglês | MEDLINE | ID: mdl-30130550

RESUMO

Klotho, which is a life extension factor, and erythropoietin (EPO) have been introduced as effective neuroprotective factors in several neurological disorders. The present study is an attempt to examine the potential role of klotho and EPO in therapeutic effect of curcumin-loaded nanoparticles (NPs) in pentylenetetrazol (PTZ)-induced kindling model. In order to induce the kindling model, PTZ was administrated intraperitoneally (i.p.) at dose of 36.5 mg/kg every other day for 20 days. Male NMRI mice received pre-treatment of free curcumin or curcumin-loaded NPs (12.5 mg/kg, i.p.) 10 days before PTZ injection and this was continued until 1 h before each PTZ injection. Immunostaining against NeuN, as a marker of neuronal maturation, and EPO was performed on hippocampal brain sections. Quantitative real time polymerase chain reaction (qRT-PCR) was conducted to assess the expression levels of tumor necrosis factor-α (TNF-α), klotho and EPO in the hippocampus. Immunostaining data indicated that treatment with curcumin-loaded NPs significantly alleviates the neuronal cell death in PTZ receiving animals. Curcumin-loaded NPs effectively upregulated the levels of EPO and klotho in PTZ receiving animals. Furthermore, mRNA level of TNF-α was considerably reduced in animals undergone curcumin-loaded NPs treatment. Overall, the results of this study suggest that downregulation of TNF-α and consequent upregulation of klotho and EPO might contribute to the neuroprotective effect of curcumin-loaded NPs in experimental model of epilepsy.


Assuntos
Curcumina/administração & dosagem , Epilepsia/tratamento farmacológico , Eritropoetina/metabolismo , Glucuronidase/metabolismo , Fármacos Neuroprotetores/administração & dosagem , Animais , Doença Crônica , Proteínas de Ligação a DNA , Modelos Animais de Doenças , Portadores de Fármacos , Epilepsia/metabolismo , Epilepsia/patologia , Hipocampo/efeitos dos fármacos , Hipocampo/metabolismo , Hipocampo/patologia , Excitação Neurológica/efeitos dos fármacos , Proteínas Klotho , Masculino , Camundongos , Nanopartículas , Proteínas do Tecido Nervoso/metabolismo , Neurônios/efeitos dos fármacos , Neurônios/metabolismo , Neurônios/patologia , Neuroproteção/efeitos dos fármacos , Neuroproteção/fisiologia , Proteínas Nucleares/metabolismo , Pentilenotetrazol , Distribuição Aleatória , Fator de Necrose Tumoral alfa/metabolismo , Regulação para Cima/efeitos dos fármacos
4.
Life Sci ; 205: 63-72, 2018 Jul 15.
Artigo em Inglês | MEDLINE | ID: mdl-29730168

RESUMO

In recent years, inactivation of A2A adenosine receptors has been emerged as a novel strategy for treatment of several neurodegenerative diseases. Although numerous studies have shown the beneficial effects of A2A receptors blockade on spatial memory, the impacts of selective adenosine A2A receptors on memory performance has not yet been examined in the context of demyelination. In the present study, we evaluated the effect of A2A receptor antagonist SCH58261 on spatial memory and myelination in an experimental model of focal demyelination in rat fimbria. Demyelination was induced by local injection of lysolecithin (LPC) 1% (2 µl) into the hippocampus fimbria. SCH58261 (20 µg/0.5 µl or 40 µg/0.5 µl) was daily injected intracerebroventricularly (i.c.v.) for 10 days post LPC injection. The Morris water maze test was used to assess the spatial learning and memory on day 6 post lesion. Myelin staining and immunostaining against astrocytes/microglia were carried out 10 days post LPC injection. The administration of adenosine A2A receptor antagonist prevented the spatial memory impairment in LPC receiving animals. Myelin staining revealed that application of SCH58261 reduces the extent of demyelination areas in the fimbria. Furthermore, the level of astrocytes and microglia activation was attenuated following administration of A2A receptor antagonist. Collectively, the results of this study suggest that A2A receptor blockade can improve the spatial memory and protect myelin sheath, which might be considered as a novel therapeutic approach for multiple sclerosis disease.


Assuntos
Antagonistas do Receptor A2 de Adenosina/uso terapêutico , Doenças Desmielinizantes/induzido quimicamente , Doenças Desmielinizantes/tratamento farmacológico , Lisofosfatidilcolinas , Transtornos da Memória/etiologia , Pirimidinas/uso terapêutico , Receptor A2A de Adenosina , Memória Espacial/efeitos dos fármacos , Triazóis/uso terapêutico , Antagonistas do Receptor A2 de Adenosina/efeitos adversos , Animais , Astrócitos/efeitos dos fármacos , Doenças Desmielinizantes/patologia , Hipocampo/patologia , Injeções Intraventriculares , Ativação de Macrófagos/efeitos dos fármacos , Masculino , Aprendizagem em Labirinto/efeitos dos fármacos , Transtornos da Memória/psicologia , Microglia/efeitos dos fármacos , Pirimidinas/efeitos adversos , Ratos , Ratos Wistar , Triazóis/efeitos adversos
5.
Brain Res Bull ; 139: 190-196, 2018 05.
Artigo em Inglês | MEDLINE | ID: mdl-29522864

RESUMO

Nonylphenol (NP) has been introduced as the most common endocrine disturbing-chemical (EDC) in the environment. NP exerts several adverse effects on the reproductive system, immune system, and central nervous system (CNS) via its potent hormonal activity. In this study, the correlation between NP concentration and the resulting memory impairment and induction of anxiety was examined in adult rats. NP (at doses of 0.2 or 2 mg/kg) and corn oil (as NP vehicle) were orally administrated for 35 days. On day 36, animals were evaluated for anxiety and cognitive performance using elevated plus maze and Morris water maze test, respectively. Rats were sacrificed afterwards for serum, cerebrospinal fluid (CSF), amygdala, and hippocampus NP level measurement using high performance liquid chromatography (HPLC). The behavioral results indicated that NP exposure at the dose of 2 mg/kg significantly reduces spatial learning and memory. Additionally, anxiety-like behavior was increased in animals received NP exposure compared to the vehicle group. Analysis of HPLC results showed that high quantity of NP is accumulated in hippocampus and amygdala tissues. Regression analysis showed a significant linear correlation between NP concentration and behavioral impairment. Overall, these data demonstrate the significant relationship between NP concentration in particular brain regions and the behavioral deficit.


Assuntos
Ansiedade/induzido quimicamente , Encéfalo/metabolismo , Deficiências da Aprendizagem/induzido quimicamente , Fenóis/toxicidade , Análise de Variância , Animais , Ansiedade/patologia , Encéfalo/efeitos dos fármacos , Encéfalo/patologia , Química Encefálica , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Deficiências da Aprendizagem/patologia , Modelos Lineares , Locomoção/efeitos dos fármacos , Masculino , Aprendizagem em Labirinto/efeitos dos fármacos , Fenóis/metabolismo , Ratos , Ratos Wistar , Tempo de Reação/efeitos dos fármacos
6.
Behav Brain Res ; 337: 131-138, 2018 Jan 30.
Artigo em Inglês | MEDLINE | ID: mdl-28939403

RESUMO

Piperine has been shown to have antioxidant activity and a cognitive-enhancing effect following long-term oral administration. In a comparative study of memantine, the current investigation threw light on the cognitive benefits of piperine. Lipid peroxidation and the ferric reducing antioxidant power (FRAP) of cerebrospinal fluid (CSF) and hippocampus in streptozotocin (STZ)-induced experimental dementia of the Alzheimer's type was measured. After reaching a criterion in a memory test, STZ-induced rats received piperine [2.5, 5, and 10mg/kg, intraperitoneally (i.p.)], vehicle, and memantine (10mg/kg, i.p.) for two weeks after the first STZ administration, or two weeks before and one week after, as a preventive approach. After the behavioral studies, samples were taken for biochemical and histological assays. An appropriate concentration of piperine (2.5mg/kg), on a daily basis, effectively increased the number of correct (non-repeated) arm entries and repressed reentry to a previously visited arm, in terms of reference errors as well as memantine (10mg/kg, i.p.), irrespective of the dose administered. The cognitive-enhancing effect induced by piperine at a relevant dose was simultaneous with CSF and hippocampal malonaldehyde decrement, and the redox balance was established to some extent by maintaining the FRAP levels of CSF near to those of the control. Similarly, the neuroprotective properties of piperine are in accordance with histopathological outcomes, which have shown an increased number of live cresyl violet (CV)-positive neurons in a dentate gyrus (DG) subregion. Therefore, the effects of piperine on the redox balance of CSF and hippocampal neurons may certainly contribute to the cognitive-enhancing activity of the drug.


Assuntos
Alcaloides/uso terapêutico , Benzodioxóis/uso terapêutico , Transtornos Cognitivos , Inibidores das Enzimas do Citocromo P-450/uso terapêutico , Hipocampo/metabolismo , Malondialdeído/líquido cefalorraquidiano , Memantina/líquido cefalorraquidiano , Piperidinas/uso terapêutico , Alcamidas Poli-Insaturadas/uso terapêutico , Análise de Variância , Animais , Antibióticos Antineoplásicos/toxicidade , Aprendizagem da Esquiva/efeitos dos fármacos , Transtornos Cognitivos/líquido cefalorraquidiano , Transtornos Cognitivos/induzido quimicamente , Transtornos Cognitivos/tratamento farmacológico , Transtornos Cognitivos/patologia , Relação Dose-Resposta a Droga , Hipocampo/efeitos dos fármacos , Hipocampo/patologia , Peroxidação de Lipídeos/efeitos dos fármacos , Masculino , Aprendizagem em Labirinto/efeitos dos fármacos , Memória de Curto Prazo/efeitos dos fármacos , Neurônios/efeitos dos fármacos , Neurônios/patologia , Ratos , Ratos Wistar , Estreptozocina/toxicidade
7.
Int J Biol Macromol ; 107(Pt A): 973-983, 2018 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-28939512

RESUMO

Recent evidence suggests that encapsulation of hydrophobic drugs in biodegradable polymers opens a new horizon in nanomedicine filed. Piperine, a main alkaloid form of black pepper possesses potent anticonvulsant activity. However, the low water solubility of piperine has limited its clinical application. In this study, piperine was loaded on chitosan-sodium tripolyphosphate nanoparticles (CS-STPP NPs) and the effect of piperine NPs on seizures behavior and astrocytes activation was assessed in pentylentetrazol (PTZ)-induced kindling model. Animals have received the daily injection of free piperine or piperine NPs at doses of 5 or 10mg/kg, 10days before PTZ injections and their intraperitoneally (i.p) administration continued until the last PTZ injection. The neuroprotective effects of piperine NPs were evaluated using nissl staining and immunostaining against NeuN. Astrocytes activation was examined by GFAP immunostaining. Behavioral data showed that piperine NPs have inhibited the development of seizure parameters compared to the free piperine groups. In addition, the levels of cell loss and astrocytes activation were reduced in piperine NPs groups. In conclusion, these data suggest that piperine NPs enhance the neuroprotection and ameliorate the astrocytes activation in chemical kindling model of epilepsy. This may provide an effective therapeutic strategy for the treatment of epilepsy disorder.


Assuntos
Alcaloides/administração & dosagem , Benzodioxóis/administração & dosagem , Epilepsia/tratamento farmacológico , Nanopartículas/administração & dosagem , Piperidinas/administração & dosagem , Alcamidas Poli-Insaturadas/administração & dosagem , Alcaloides/química , Animais , Astrócitos/efeitos dos fármacos , Astrócitos/patologia , Benzodioxóis/química , Quitosana/administração & dosagem , Quitosana/química , Modelos Animais de Doenças , Epilepsia/induzido quimicamente , Epilepsia/patologia , Humanos , Interações Hidrofóbicas e Hidrofílicas/efeitos dos fármacos , Excitação Neurológica/efeitos dos fármacos , Excitação Neurológica/patologia , Camundongos , Nanopartículas/química , Neurônios/efeitos dos fármacos , Neurônios/patologia , Compostos Organofosforados/administração & dosagem , Compostos Organofosforados/química , Pentilenotetrazol/toxicidade , Piperidinas/química , Alcamidas Poli-Insaturadas/química , Ácidos Esteáricos/administração & dosagem , Ácidos Esteáricos/química
8.
Prog Neuropsychopharmacol Biol Psychiatry ; 79(Pt B): 462-471, 2017 10 03.
Artigo em Inglês | MEDLINE | ID: mdl-28778407

RESUMO

Despite several beneficial effects of curcumin, its medical application has been hampered due to low water solubility. To improve the aqueous solubility of curcumin, it has been loaded on chitosan (CS)-alginate (ALG) - sodium tripolyphosphate (STPP) nanoparticles (NPs). Then, the effect of curcumin NPs on memory improvement and glial activation was investigated in pentylenetetrazol (PTZ)-induced kindling model. Male NMRI mice have received the daily injection of curcumin NPs at dose of 12.5 or 25mg/kg. All interventions were injected intraperitoneally (i.p), 10days before PTZ administration and the injections were continued until 1h before each PTZ injection. Spatial learning and memory was evaluated using Morris water maze test after the 7th PTZ injection. Animals have received 10 injections of PTZ and then, brain tissues were removed for histological evaluation. Nissl staining was used to determine the level of cell death in hippocampus and immunostaining method was performed against NeuN and GFAP/Iba1 for assessment of neuronal density and glial activation respectively. Behavioral results showed that curcumin NPs exhibit anticonvulsant activity and prevent cognitive impairment in fully kindled animals. The level of cell death and glial activation reduced in animals which have received curcumin NPs compared to those received free curcumin. To conclude, these findings suggest that curcumin NPs effectively ameliorate memory impairment and attenuate the level of activated glial cells in a mice model of chronic epilepsy.


Assuntos
Anticonvulsivantes/administração & dosagem , Curcumina/administração & dosagem , Epilepsia/tratamento farmacológico , Transtornos da Memória/tratamento farmacológico , Neuroglia/efeitos dos fármacos , Nootrópicos/administração & dosagem , Animais , Encéfalo/efeitos dos fármacos , Encéfalo/metabolismo , Encéfalo/patologia , Doença Crônica , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Portadores de Fármacos , Epilepsia/patologia , Epilepsia/fisiopatologia , Epilepsia/psicologia , Injeções Intraperitoneais , Excitação Neurológica , Masculino , Transtornos da Memória/patologia , Transtornos da Memória/fisiopatologia , Camundongos , Nanopartículas , Neuroglia/patologia , Neuroglia/fisiologia , Pentilenotetrazol , Distribuição Aleatória , Aprendizagem Espacial/efeitos dos fármacos , Memória Espacial/efeitos dos fármacos
9.
Neuroscience ; 344: 148-156, 2017 03 06.
Artigo em Inglês | MEDLINE | ID: mdl-28049030

RESUMO

Multiple sclerosis (MS) is an autoimmune disease in which more than 70% of patients experience visual disturbance as the earliest symptoms. Lysolecithin (LPC)-induced focal demyelination model has been developed to evaluate the effects of different therapies on myelin repair improvement. In this study, the effects of pregabalin administration on myelin repair and glial activation were investigated. Local demyelination was induced by administration of LPC (1%, 2µL) into the rat optic chiasm. Rats underwent daily injection of pregabalin (30mg/kg, i.p) or vehicle. Visual-evoked potentials (VEPs) recordings were performed for evaluating the function of optic pathway on days 3, 7, 14 and 28 post lesions. Myelin specific staining and immunostaining against GFAP and Iba1 were also carried out for assessment of myelination and glial activation respectively. Electrophysiological data indicated that pregabalin administration could significantly reduce the P1-N1 latency and increase the amplitude of VEPs waves compared to saline group. Luxol fast blue staining and immunostaining against PLP, as mature myelin marker, showed that myelin repair was improved in animals received pregabalin treatment. In addition, pregabalin effectively reduced the expression of GFAP and Iba1 as activated glial markers in optic chiasm. The present study indicates that pregabalin administration enhances myelin repair and ameliorates glial activation of optic chiasm following local injection of LPC.


Assuntos
Bainha de Mielina/efeitos dos fármacos , Doença Autoimune do Sistema Nervoso Experimental/tratamento farmacológico , Neuroglia/efeitos dos fármacos , Fármacos Neuroprotetores/farmacologia , Quiasma Óptico/efeitos dos fármacos , Pregabalina/farmacologia , Animais , Proteínas de Ligação ao Cálcio/metabolismo , Doenças Autoimunes Desmielinizantes do Sistema Nervoso Central/tratamento farmacológico , Doenças Autoimunes Desmielinizantes do Sistema Nervoso Central/patologia , Doenças Autoimunes Desmielinizantes do Sistema Nervoso Central/fisiopatologia , Potenciais Evocados Visuais/efeitos dos fármacos , Proteína Glial Fibrilar Ácida/metabolismo , Lisofosfatidilcolinas , Masculino , Proteínas dos Microfilamentos/metabolismo , Bainha de Mielina/patologia , Bainha de Mielina/fisiologia , Doença Autoimune do Sistema Nervoso Experimental/patologia , Doença Autoimune do Sistema Nervoso Experimental/fisiopatologia , Neuroglia/patologia , Neuroglia/fisiologia , Quiasma Óptico/patologia , Quiasma Óptico/fisiopatologia , Distribuição Aleatória , Ratos Wistar
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...